Aug 9, 2017

IN-SITE #7: Kiev

Double Bond Pharma IN-SITE #7 utspelar sig i Kiev, huvudstaden av Ukraina, där företagets VD Igor Lokot möter blivande samarbetspartners.
Jul 4, 2017

Predictive biomarkers show the way

One of the important factors in drug development process is biomarker co-development. It is usually considered that efficacy-predicting biomarkers can potentially secure a...
Nov 1, 2016

Hopes and hypes in cancer treatments. Part V

In the majority of cancer cases, the disease (presence of tumor) is detected at the late stage, when the treatment options are limited. Liver and brain cancers, for example, are those that often develop with...
Sep 7, 2016

Temozolomide and MGMT Methylation 101

When we acquired Temodex - a new drug against brain cancer and one of DBP's front-line products - in the end of last year, I was several times in a position to explain the advantages of the drug to journalists, investors and...